Compounds > 2,2'-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride
Page last updated: 2024-12-06

2,2'-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID70677
SCHEMBL ID49774
MeSH IDM0269891

Synonyms (53)

Synonym
4,4'-(hexafluoroisopropylidene)bis(phthalic anhydride)
c19h6f6o6
1,3-isobenzofurandione, 5,5'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis-
4,4'-(hexafluoroisopropylidene)diphthalic anhydride, 99%
5-[2-(1,3-dioxo-2-benzofuran-5-yl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-benzofuran-1,3-dione
4,4'-(hexafluoroisopropylidene)diphthalic anhydride ,
AKOS005063720
1107-00-2
H0771
5,5'-(perfluoropropane-2,2-diyl)bis(isobenzofuran-1,3-dione)
A802235
2,2'-bis(3,4-anhydrodicarboxylphenyl)hexafluoropropane
2,2-bis(3,4-anhydrodicarboxyphenyl)hexafluoropropane
2,2'-bis-(3,4-dicarboxyphenyl)hexafluoropropane dianhydride
2,2-bis(3,4-dicarboxyphenyl)-1,1,1,3,3,3-hexafluoropropane dianhydride
4,4'-(hexafluoroisopropylidene)diphthalicanhydride
4,4'-(hexafluoroisopropylidene)bis-phthalic anhydride
n2ga6jcu7h ,
2,2'-bis(3,4-dicarboxyphenyl)hexafluoropropane dianhydride
4,4'-(2,2,2-trifluoro-1-(trifluoromethyl)ethylidene)diphthalic anhydride
unii-n2ga6jcu7h
einecs 214-170-0
1,3-isobenzofurandione, 5,5'-(2,2,2-trifluoro-1-(trifluoromethyl)ethylidene)bis-
5,5'-(1,1,1,3,3,3-hexafluoropropane-2,2-diyl)bis(2-benzofuran-1,3-dione)
FT-0609163
6fda
5,5'-(perfluoropropane-2,2-diyl)diisobenzofuran-1,3-dione
SCHEMBL49774
H1438
DTXSID7061487
5,5'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]-bis(1,3-isobenzofurandione)
5,5'[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]-bis-1,3-isobenzofurandione
5,5'-(1,1,1,3,3,3-hexafluoro-2,2-propanediyl)bis(2-benzofuran-1,3-dione)
W-108684
CS-W008485
mfcd00039143
4,4'-(hexafluoroisopropylidene)diphthalic anhydride(6fda)
4,4'-(hexafluoroisopropylidene)diphthalic anhydride, 98+ percent
4,4-(hexafluoroisopropylidene)diphthalic anhydride
STL575550
4,4'-(hexafluoroisopropylidene)diphthalic anhydride (purified by sublimation)
AS-14396
Q17189219
1,3-isobenzofurandione,5,5'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis-
AMY6823
4,4 inverted exclamation mark -(hexafluoroisopropylidene) diphthalic anhydride
5-[2-(1,3-dioxo-1,3-dihydro-2-benzofuran-5-yl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-1,3-dihydro-2-benzofuran-1,3-dione
5,5'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[1,3-isobenzofurandione]
h-0771
6fpa
phthalic anhydride, 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]di-
[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphthalic anhydride
hexafluoroisopropylidene-2,2-bis(phthalic anhydride)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.31 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
3-phenylenediamine
1,3-phenylenediamine : A phenylenediamine taht is benzene substituted at positions 1 and 3 with amino functions.		2.110phenylenediamine
3,5-diaminobenzoic acid
3,5-diaminobenzoic acid: RN given refers to parent cpd		2.110
fluorine
Fluorine: A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries.		2.110diatomic fluorine;
gas molecular entity		NMR chemical shift reference compound
3-iodobenzylguanidine
3-Iodobenzylguanidine: A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.		3.1410organoiodine compound
ConditionIndicatedRelationship StrengthStudiesTrials
Dysautonomia
[description not available]		02.9610
Cardiac Diseases
[description not available]		02.9610
Idiopathic Parkinson Disease
[description not available]		02.9610
Heart Diseases
Pathological conditions involving the HEART including its structural and functional abnormalities.		02.9610
Parkinson Disease
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)		02.9610